Is Avalo Therapeutics, Inc. (AVTX) a Buy, Sell, or Hold?
NASDAQ : AVTX
Avalo Therapeutics, Inc. — Competitors
$18.84 USD
$0.31 (1.67%)
- Volume
- 734.42K
- Average Volume
- 1.94M
- Market Capitalization
- $212.78M
- P/E Ratio
- -3.23
- Dividend Yield
- 0.00%
- Price Target
- $45.00
- Year High
- $24.27
- Year Low
- $8.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.66
AVTX vs. The Competition
| Properties | AVTX | AARD | BDTX | CHRS |
|---|---|---|---|---|
| Market Cap | $212.78M | $164.57M | $102.57M | $177.49M |
| Shares Outstanding | $11.29M | $21.88M | $57.3M | $122.41M |
| P/E Ratio | -3.23 | -2.34 | -2.42 | -1.42 |
| EPS | -4.21 | -3.2 | -0.74 | -0.85 |
| Day Low | 18.33 | 7.21 | 1.76 | 1.435 |
| Day High | 19.36 | 7.88 | 1.825 | 1.525 |
| Year Low | 8.003 | 3.35 | 1.6 | 0.81 |
| Year High | 24.27 | 17.94 | 4.94 | 2.616 |
| Average Price 50 | 17.0436 | 5.0704 | 1.9138 | 1.4821 |
| Average Price 200 | 16.54178 | 8.5081 | 2.63208 | 1.59823 |
| Volume | 734.42K | 190.61K | 369.27K | 808.09K |
| Average Volume | - | - | - | - |